JAGX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Jaguar Health Inc (JAGX).


$7.68M Market Cap.

As of 04/01/2024 5:00 PM ET (MRY) • Disclaimer

JAGX Market Cap. (MRY)


JAGX Shares Outstanding (MRY)


JAGX Assets (MRY)


Total Assets

$50.76M

Total Liabilities

$45.87M

Total Investments

$0

JAGX Income (MRY)


Revenue

$9.76M

Net Income

-$41.30M

Operating Expense

$42.02M

JAGX Cash Flow (MRY)


CF Operations

-$33.24M

CF Investing

$0

CF Financing

$34.23M

JAGX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

0%

0%

-

2019

$0

0%

-

0%

-

JAGX Balance Sheet (MRY)


Metric

2023

2022

2021

2020

Total Assets

$50,763,000 (6.98%)

$47,449,000 (-10.92%)

$53,265,000 (24.33%)

$42,843,000 (17.67%)

Assets Current

$27,963,000 (25.28%)

$22,321,000 (-21.50%)

$28,434,000 (59.81%)

$17,792,000 (86.85%)

Assets Non-Current

$22,800,000 (-9.26%)

$25,128,000 (1.20%)

$24,831,000 (-0.88%)

$25,051,000 (-6.83%)

Goodwill & Intangible Assets

$20,116,000 (-10.35%)

$22,439,000 (-0.94%)

$22,651,000 (-6.93%)

$24,337,000 (-6.48%)

Shareholders Equity

$4,961,000 (851.67%)

-$660,000 (-105.68%)

$11,611,000 (-32.50%)

$17,202,000 (61.17%)

Property Plant & Equipment Net

$1,672,000 (-1.47%)

$1,697,000 (-2.13%)

$1,734,000 (156.13%)

$677,000 (-46.40%)

Cash & Equivalents

$6,469,000 (18.28%)

$5,469,000 (-67.93%)

$17,051,000 (110.77%)

$8,090,000 (108.34%)

Accumulated Other Comprehensive Income

-$652,000 (4.12%)

-$680,000 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$9,189,000 (30.82%)

$7,024,000 (43.35%)

$4,900,000 (76.13%)

$2,782,000 (30.67%)

Trade & Non-Trade Receivables

$2,184,000 (-11.47%)

$2,467,000 (15.07%)

$2,144,000 (-52.98%)

$4,560,000 (169.19%)

Trade & Non-Trade Payables

$4,974,000 (-14.36%)

$5,808,000 (17.83%)

$4,929,000 (3.57%)

$4,759,000 (-11.08%)

Accumulated Retained Earnings (Deficit)

-$308,248,000 (-15.47%)

-$266,949,000 (-21.62%)

-$219,494,000 (-31.51%)

-$166,899,000 (-25.40%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$37,094,000 (6.48%)

$34,835,000 (18.63%)

$29,365,000 (81.15%)

$16,210,000 (114.28%)

Debt Current

$5,215,000 (-68.14%)

$16,366,000 (377.98%)

$3,424,000 (-9.63%)

$3,789,000 (-46.75%)

Debt Non-Current

$31,879,000 (72.61%)

$18,469,000 (-28.80%)

$25,941,000 (108.85%)

$12,421,000 (2660.22%)

Total Liabilities

$45,866,000 (-6.03%)

$48,808,000 (17.86%)

$41,412,000 (61.51%)

$25,641,000 (61.85%)

Liabilities Current

$13,987,000 (-53.90%)

$30,339,000 (96.10%)

$15,471,000 (17.03%)

$13,220,000 (-14.11%)

Liabilities Non-Current

$31,879,000 (72.61%)

$18,469,000 (-28.80%)

$25,941,000 (108.85%)

$12,421,000 (2660.22%)

JAGX Income Statement (MRY)


Metric

2023

2022

2021

2020

Revenues

$9,761,000 (-18.36%)

$11,956,000 (175.80%)

$4,335,000 (-53.81%)

$9,385,000 (62.51%)

Cost of Revenue

$2,037,000 (0.89%)

$2,019,000 (-13.46%)

$2,333,000 (-28.87%)

$3,280,000 (-14.05%)

Selling General & Administrative Expense

$23,048,000 (-13.69%)

$26,705,000 (2.72%)

$25,997,000 (23.82%)

$20,996,000 (2.73%)

Research & Development Expense

$18,596,000 (5.38%)

$17,647,000 (17.03%)

$15,079,000 (135.13%)

$6,413,000 (10.19%)

Operating Expenses

$42,015,000 (-5.27%)

$44,352,000 (3.84%)

$42,710,000 (30.40%)

$32,752,000 (5.97%)

Interest Expense

$6,382,000 (-49.84%)

$12,723,000 (51.09%)

$8,421,000 (201.61%)

$2,792,000 (-51.28%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$41,901,000 (13.42%)

-$48,395,000 (7.99%)

-$52,600,000 (-55.58%)

-$33,809,000 (12.27%)

Net Income to Non-Controlling Interests

-$601,000 (36.13%)

-$941,000 (-18720.00%)

-$5,000 (0%)

$0 (0%)

Net Income

-$41,300,000 (12.97%)

-$47,454,000 (9.77%)

-$52,595,000 (-55.57%)

-$33,809,000 (12.27%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$4,839,000 (-21.79%)

Net Income Common Stock

-$41,300,000 (12.97%)

-$47,454,000 (9.77%)

-$52,595,000 (-36.09%)

-$38,648,000 (13.59%)

Weighted Average Shares

$23,068,423 (1658.91%)

$1,311,519 (120.00%)

$596,154 (247.12%)

$171,741 (678.27%)

Weighted Average Shares Diluted

$23,068,423 (1658.91%)

$1,311,519 (120.00%)

$596,154 (247.12%)

$171,741 (678.27%)

Earning Before Interest & Taxes (EBIT)

-$34,918,000 (-0.54%)

-$34,731,000 (21.38%)

-$44,174,000 (-42.42%)

-$31,017,000 (5.43%)

Gross Profit

$7,724,000 (-22.27%)

$9,937,000 (396.35%)

$2,002,000 (-67.21%)

$6,105,000 (211.64%)

Operating Income

-$34,291,000 (0.36%)

-$34,415,000 (15.46%)

-$40,708,000 (-52.77%)

-$26,647,000 (7.95%)

JAGX Cash Flow Statement (MRY)


Metric

2023

2022

2021

2020

Net Cash Flow from Investing

$0 (0%)

-$1,675,000 (-27816.67%)

-$6,000 (14.29%)

-$7,000 (0%)

Net Cash Flow from Financing

$34,227,000 (47.65%)

$23,181,000 (-47.24%)

$43,937,000 (125.41%)

$19,492,000 (-10.47%)

Net Cash Flow from Operations

-$33,242,000 (-0.42%)

-$33,104,000 (5.34%)

-$34,970,000 (-128.89%)

-$15,278,000 (25.32%)

Net Cash Flow / Change in Cash & Cash Equivalents

$1,000,000 (108.63%)

-$11,582,000 (-229.25%)

$8,961,000 (113.00%)

$4,207,000 (219.92%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

-$1,675,000 (-27816.67%)

-$6,000 (14.29%)

-$7,000 (0%)

Issuance (Repayment) of Debt Securities

-$953,000 (-135.05%)

$2,719,000 (-66.47%)

$8,110,000 (-32.77%)

$12,063,000 (12163.00%)

Issuance (Purchase) of Equity Shares

$33,336,000 (62.92%)

$20,462,000 (-39.07%)

$33,581,000 (332.97%)

$7,756,000 (17.04%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$15,000 (-6.25%)

$16,000 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$2,112,000 (-36.35%)

$3,318,000 (-16.51%)

$3,974,000 (40.72%)

$2,824,000 (-9.75%)

Depreciation Amortization & Accretion

$2,388,000 (4.19%)

$2,292,000 (26.42%)

$1,813,000 (-20.48%)

$2,280,000 (18.26%)

JAGX Financial Metrics (MRY)


Metric

2023

2022

2021

2020

Gross Margin

79.10% (-4.81%)

83.10% (79.87%)

46.20% (-29.03%)

65.10% (92.04%)

Profit Margin

-423.10% (-6.60%)

-396.90% (67.29%)

-1213.30% (-194.63%)

-411.80% (46.83%)

EBITDA Margin

-333.30% (-22.85%)

-271.30% (72.24%)

-977.20% (-219.14%)

-306.20% (42.71%)

Return on Average Equity (ROAE)

-855.60% (38.03%)

-1380.70% (-535.68%)

-217.20% (53.93%)

-471.50% (28.30%)

Return on Average Assets (ROAA)

-80.50% (14.54%)

-94.20% (-12.28%)

-83.90% (18.62%)

-103.10% (14.30%)

Return on Sales (ROS)

-357.70% (-23.13%)

-290.50% (71.49%)

-1019.00% (-208.32%)

-330.50% (41.80%)

Return on Invested Capital (ROIC)

-99.70% (26.26%)

-135.20% (7.65%)

-146.40% (-101.33%)

10979.50% (62.29%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.09 (52.78%)

-0.18 (79.64%)

-0.88 (-8.47%)

-0.81 (-815.73%)

Price to Sales Ratio (P/S)

0.36 (-49.93%)

0.71 (-93.33%)

10.73 (219.64%)

3.36 (387.08%)

Price to Book Ratio (P/B)

1.55 (108.10%)

-19.12 (-542.87%)

4.32 (-0.14%)

4.32 (12.63%)

Debt to Equity Ratio (D/E)

9.24 (112.50%)

-73.95 (-2173.23%)

3.57 (139.24%)

1.49 (0.47%)

Earnings Per Share (EPS)

-1.79 (95.05%)

-36.18 (58.99%)

-88.22 (60.79%)

-225.01 (88.90%)

Sales Per Share (SPS)

0.42 (-95.36%)

9.12 (25.36%)

7.27 (-86.69%)

54.65 (-79.12%)

Free Cash Flow Per Share (FCFPS)

-1.44 (94.57%)

-26.52 (54.80%)

-58.67 (34.08%)

-89 (90.40%)

Book Value Per Share (BVPS)

0.21 (142.74%)

-0.5 (-102.58%)

19.48 (-80.55%)

100.16 (-79.29%)

Tangible Assets Book Value Per Share (TABVPS)

1.33 (-93.03%)

19.07 (-62.87%)

51.35 (-52.34%)

107.76 (-77.10%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1 (0.00%)

-1 (66.67%)

-3 (-200.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.23 (-14.10%)

-1.08 (30.36%)

-1.55 (46.06%)

-2.87 (-92.49%)

Asset Turnover

0.19 (-19.83%)

0.24 (243.48%)

0.07 (-72.40%)

0.25 (61.29%)

Current Ratio

2 (171.60%)

0.74 (-59.96%)

1.84 (36.55%)

1.35 (117.45%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$33,242,000 (4.42%)

-$34,779,000 (0.56%)

-$34,976,000 (-128.83%)

-$15,285,000 (25.28%)

Enterprise Value (EV)

$40,001,395 (14.42%)

$34,959,069 (-46.70%)

$65,595,186 (-20.46%)

$82,470,919 (79.19%)

Earnings Before Tax (EBT)

-$41,300,000 (12.97%)

-$47,454,000 (9.77%)

-$52,595,000 (-55.57%)

-$33,809,000 (12.25%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$32,530,000 (-0.28%)

-$32,439,000 (23.42%)

-$42,361,000 (-47.41%)

-$28,737,000 (6.91%)

Invested Capital

$47,285,000 (96.72%)

$24,037,000 (-12.46%)

$27,457,000 (104.81%)

$13,406,000 (1112.54%)

Working Capital

$13,976,000 (274.31%)

-$8,018,000 (-161.85%)

$12,963,000 (183.53%)

$4,572,000 (177.89%)

Tangible Asset Value

$30,647,000 (22.54%)

$25,010,000 (-18.31%)

$30,614,000 (65.43%)

$18,506,000 (78.18%)

Market Capitalization

$7,684,395 (-39.11%)

$12,621,069 (-74.83%)

$50,140,186 (-32.59%)

$74,378,919 (81.53%)

Average Equity

$4,827,000 (40.44%)

$3,437,000 (-85.80%)

$24,209,750 (195.38%)

$8,196,250 (20.51%)

Average Assets

$51,310,500 (1.84%)

$50,381,750 (-19.64%)

$62,693,000 (67.26%)

$37,483,250 (0.78%)

Invested Capital Average

$35,025,500 (36.38%)

$25,681,750 (-14.88%)

$30,171,750 (10780.27%)

-$282,500 (41.73%)

Shares

50,755,580 (2521.08%)

1,936,441 (201.25%)

642,807 (58.48%)

405,597 (78.41%)

Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.